280 related articles for article (PubMed ID: 20878997)
1. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia.
Yoshida M; Inadome A; Masunaga K; Nagata T; Yoshiyasu T
Neurourol Urodyn; 2010 Sep; 29(7):1276-81. PubMed ID: 20878997
[TBL] [Abstract][Full Text] [Related]
2. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia.
Simaioforidis V; Papatsoris AG; Chrisofos M; Chrisafis M; Koritsiadis S; Deliveliotis C
Int J Urol; 2011 Mar; 18(3):243-8. PubMed ID: 21332817
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of tamsulosin hydrochloride for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: data from China.
Sun YH; Liu ZY; Zhang ZS; Xu CL; Ji JT; Wu YY; Shao Y; Zhang LM
Chin Med J (Engl); 2011 Jan; 124(1):56-60. PubMed ID: 21362308
[TBL] [Abstract][Full Text] [Related]
5. Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: a prospective open-label long-term study using frequency-volume chart.
Kojima Y; Sasaki S; Imura M; Kubota Y; Hayashi Y; Kohri K
Neurourol Urodyn; 2012 Jan; 31(1):80-5. PubMed ID: 22038792
[TBL] [Abstract][Full Text] [Related]
6. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
[TBL] [Abstract][Full Text] [Related]
7. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study.
Montorsi F; Roehrborn C; Garcia-Penit J; Borre M; Roeleveld TA; Alimi JC; Gagnier P; Wilson TH
BJU Int; 2011 May; 107(9):1426-31. PubMed ID: 21348912
[TBL] [Abstract][Full Text] [Related]
8. Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).
Gross AJ; Busse M; Leonard J; Schumacher H
Prostate Cancer Prostatic Dis; 2005; 8(3):210-4. PubMed ID: 15883586
[TBL] [Abstract][Full Text] [Related]
9. The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.
Gorgel SN; Sefik E; Kose O; Olgunelma V; Sahin E
Int Braz J Urol; 2013; 39(5):657-62. PubMed ID: 24267123
[TBL] [Abstract][Full Text] [Related]
10. Effect of naftopidil on nocturia after failure of tamsulosin.
Oh-oka H
Urology; 2008 Nov; 72(5):1051-5. PubMed ID: 18817955
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].
Iwaki H; Narita M; Soga H; Sakano Y; Konishi T; Okada Y
Hinyokika Kiyo; 2010 Apr; 56(4):209-13. PubMed ID: 20448444
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.
Tsuritani S; Nozaki T; Okumura A; Kimura H; Kazama T
Urol Int; 2010; 85(1):80-7. PubMed ID: 20516676
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
[TBL] [Abstract][Full Text] [Related]
14. [The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
Nakatsu H; Naoi M; Sekiyama K; Hamano S; Suzuki N; Tanaka M; Murakami S
Hinyokika Kiyo; 2007 Jan; 53(1):13-8. PubMed ID: 17310763
[TBL] [Abstract][Full Text] [Related]
15. [Impact of nocturia on sleep quality in patients with lower urinary tract symptoms suggesting benign prostatic hyperplasia (LUTS/BPH). The NocSu Study].
Hernández C; Estivill E; Cantalapiedra A
Actas Urol Esp; 2010 May; 34(5):450-9. PubMed ID: 20470718
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment to Tamsulosin versus transurethral resection of the prostate: effect on nocturia due to benign prostatic hyperplasia.
Milićević S
Int J Urol; 2011 Mar; 18(3):248-9. PubMed ID: 21332818
[No Abstract] [Full Text] [Related]
17. Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia.
Tsujimura A; Takao T; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Ueda T; Kiuchi H; Hirai T; Tsujimoto Y; Miura H; Kanno N; Higashino M; Nakamura Y; Nishimura K; Nonomura N
Urology; 2011 Nov; 78(5):1058-62. PubMed ID: 21908025
[TBL] [Abstract][Full Text] [Related]
18. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
[TBL] [Abstract][Full Text] [Related]
19. Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study.
Ukimura O; Kanazawa M; Fujihara A; Kamoi K; Okihara K; Miki T;
Int J Urol; 2008 Dec; 15(12):1049-54. PubMed ID: 19120513
[TBL] [Abstract][Full Text] [Related]
20. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
